Back to search
FDAFDA · Food and drugs·Recall number Z-1906-2013

Nova Max Plus Monitor System (Kit w/10 Count Vials International) Catalog Number: 45507 Product Usage: The Nova Max Glucose Test Strips are for use with the Nova Max Family of Glucose Monitors (Nova Max, Nova Max Plus, Nova Max Link, BD Logic and Paradigm Link). These monitors are intended to be used for the quantitative measurement of glucose in fresh capillary whole blood. They are intended for use by people with diabetes mellitus in the home and by healthcare professionals in clinical settings as an aid to monitor the effectiveness of diabetes control

Published August 21, 2013 · Recall initiated: July 15, 2013

Summary

FDA records medical device Class I recall Z-1906-2013, published August 21, 2013 and initiated July 15, 2013. Recalling firm: Nova Biomedical Corporation; Status: Terminated; Reported quantity: 13,600 kits; Lot: 1010112059 12/31/2013 1010213171 04/30/2015 1010312066 12/31/2013 1010712339 10/31/2014. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Reports of false abnormally high glucose readings from test strips

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nova Biomedical Corporation
Distributor
Worldwide Distribution - USA Nationwide and the countries of Chile, England , Peru, Nicaragua
Lot
1010112059 12/31/2013 1010213171 04/30/2015 1010312066 12/31/2013 1010712339 10/31/2014
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Nova Max Plus Monitor System (Kit w/10 Count Vials International) Catalog Number: 45507 Product Usage: The Nova Max Glucose Test Strips are for use with the Nova Max Family of Glucose Monitors (Nova Max, Nova Max Plus, Nova Max Link, BD Logic and Paradigm Link). These monitors are intended to be used for the quantitative measurement of glucose in fresh capillary whole blood. They are intended for use by people with diabetes mellitus in the home and by healthcare professionals in clinical settings as an aid to monitor the effectiveness of diabetes control recalled?

Yes. FDA published recall Z-1906-2013 on August 21, 2013. Reported hazard: Reports of false abnormally high glucose readings from test strips

What should I do if I have this product?

Voluntary: Firm initiated · Letter